Suchergebnisse

BackgroundThe prevalence for diabetes, prediabetes, and gestational diabetes in Vietnam are low relative to other parts of the world, but they are increasing at alarming rates. These changes have occurred in the setting of economic and cultural transitions.ObjectivesThe aim of this study was to provide relevant information depicting the diabetes burden in Vietnam.MethodsLiterature was reviewed using PubMed and local Vietnamese sources, including papers published in the Vietnamese language.FindingsIn 2012, the prevalence of diabetes was 5.4% and prediabetes 13.7%. In 2005, the prevalence of obesity was 1.7%. There is a dual burden of over- and undernutritionobserved in Vietnam. Diabetes is associated with an increased waist-to-hip ratio despite normal body mass index. Nutritional transitions occurred with increased protein, fat, and fast foods, and with decreased fresh fruits and vegetables. Tobacco use is very high in Vietnam with 66% of adult men currently smoking. Challenges include endocrinology training, health care coverage, patient education, and lack of coordination among government and specialist agencies.ConclusionDiabetes is a growing problem in Vietnam and is associated with obesity, changes in dietary patterns, and other cultural transitions. More research is needed to better understand this health care problem and to devise targeted interventions.

In Diabetes & C-Peptide: Scientific and Clinical Aspects, a renowned group of leading researchers and physicians offers a comprehensive overview of the role of C-Peptide in type 1 diabetes. The book is organized in five sections. An Introductory section provides the background and key features of C-peptide's physiological function and how its deficiency contributes to complications. The second section describes up-to-date information on the biochemical and molecular actions of C-peptide, including membrane binding, interactions with insulin as well as the interaction between C-peptide and zinc

Diabetes is regarded as one of the most challenging global health issues of the 21st century. Especially countries with weak health infrastructure are struggling to deal with the increased demands this chronic disease entails.Tracing the effects of a diagnostic device, the glucometer, this book examines how it contributes to the making of diabetes in contemporary Uganda. Arlena S. Liggins demonstrates that depending on who uses the glucometer, the outcomes may go far beyond diagnosis. The book draws a complex picture of hopes and misplaced expectations, of trust and mistrust in a technology to which access in the first place is all but a given

Intro -- Acknowledgements -- Contents -- Notes on Contributors -- Abbreviations -- List of Figures -- Introduction -- What This Book Offers -- Defining Diabetes: Contemporary Understandings -- Diabetes as Disease -- Diabetes as Metaphor -- Diabetes as Disability -- Diabetes as a Site of Resistance -- Representations of Diabetes -- Situating this Volume in Disability Studies -- References -- Part I: Social Media, Social Worlds & -- amp -- Activism -- Diabetes Twitter: A Communal Retort to Capitalism -- Social Media and the Crafting of a Collective Diabetes Persona -- Retorting Pharmaceutical Corporations -- Correcting and Educating Politicians -- Holding Diabetes Nonprofits Accountable -- Capitalism and Diabetes Twitter's Discontents -- What's in a Name? The Diabetes Civil War -- Introduction -- Diabetes in the Public Sphere -- Investigating Language Used in a Virtual Public Sphere -- Ethical Concerns of Internet Research -- War of Words -- Classification -- Expert Patient Ethos -- Certainty of Numbers -- Medical Knowledge -- "Expert" Testimony -- Concluding Connections -- References -- The #insulin4all Movement: A Few Committed Individuals Isn't Enough -- Introduction -- Diabetes as Disability -- Founding and Organization -- #insulin4all Founding and Organization -- ACT UP Founding and Organization -- Parallels and Influences -- Noteworthy Departures -- Strategy and Milestones -- The Legislative Goals of #insulin4all -- Supercrip and the Human Cost of Activism -- Looking Ahead -- References -- One or Many Voices: Narratives from #insulin4all -- Introduction -- Methods and Data -- Diffusion and Content Analysis -- Discussion -- References -- Part II: Film, Television, Visual Art and Performance -- Laughing to Keep from Dying: Black Americans with Diabetes in Sitcoms and Comedies -- Blackness, Disability, and Comedy.

BackgroundDiabetes is a noncommunicable disease that has attained great significance in the sub-Saharan region, with Nigeria being the most affected. Many persons with the condition suffer a reduced life expectancy and quality of life. Diabetes places an extra burden on the individuals and families affected, especially for the majority of patients unable to access quality health care.ObjectiveTo describe the elements of diabetes management in Nigeria, areas for improvement, and proposed strategies to optimize care.MethodsA systematic literature search was performed on diabetes in Nigeria. Local and nonindexed literature, PubMed, and Google Scholar were used to source information on the subject.FindingsDiabetes-related morbidity and mortality continue to increase due to population expansion, urban migration, declining physical activity, and dietary factors. The organization of diabetes care is poorly coordinated, especially at the primary and secondary tiers of the public health care system, with consequent poor outcomes. Thus life expectancy (just about 50 years), which is low in the region, is further reduced by the double jeopardy of communicable (eg, tuberculosis, HIV/AIDS, and malaria) and noncommunicable diseases, such as diabetes and its closely related comorbidity, hypertension.ConclusionsThe way forward is to improve maternal and child care, promote screening of at-risk populations, and develop strategies for primary prevention and early intervention to optimize glycemic control. Greater commitment to health care by the government and nongovernmental organizations and greater awareness by Nigerians should facilitate the desired improvements in disease prevention and glycemic control in those who are already affected.